Skip to content
en English▼
X
en English
ar العربية
zh-CN 简体中文
nl Nederlands
fr Français
de Deutsch
it Italiano
ja 日本語
ko 한국어
no Norsk bokmål
pl Polski
pt Português
ru Русский
es Español
sv Svenska
th ไทย
tr Türkçe
vi Tiếng Việt
  • About Us
    • Our Story and Mission
    • Tucker’s Message
    • Executive Committee, Management & Staff
    • Board of Directors
    • Medical and Scientific Advisors
    • Patient and Caregiver Advisors
    • Financial Information
  • Contact Us
  • News & Media
    • Announcements
    • Press Releases
Fibrolamellar Cancer Foundation
Fibrolamellar Cancer Foundation
  • About Fibro
    • What is Fibrolamellar Carcinoma?
    • Fibrolamellar FAQ’s
    • Faces of Fibrolamellar
    • A Mother’s Story
    • Caregiver Profiles
    • Newly Diagnosed
  • Treatment Options
    • Introduction
    • Surgery
    • Chemotherapy
    • Targeted therapy
    • Immunotherapy
    • Interventional radiology
    • Radiation
    • Palliative care
  • Research
    • FCF Research
      • Research Overview and Approach
      • FCF Research Priorities
      • Funded Projects
      • Overall Grant Funding and Impact
    • Scientific Publications and Presentations
    • Meet the Researchers
    • Apply for a Grant or Incentive Award
  • Resources & Events
    • Connect with Other Patients
    • Events Calendar
    • Find A Doctor
    • Helpful Resources
    • Glossary of terms
  • Clinical Trials
  • Join the Fight
    • Donate Tumor Tissue
    • Become a Grant Reviewer
    • Provide Data for Research
    • Share Your Story
    • Become a FCF Ambassador
    • Volunteer
    • Get a Fibrolamellar Calendar
    • Give
  • Giving

Home » 2022

2022

Multi-omic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma

Nearly all FLC tumors carry the fusion gene DNAJB1-PRKACA and the expressed protein chimera DNAJ-PKAc which is believed to be the driver of FLC formation. However, to identify potential new therapies for FLC, it is important to understand the specific mechanisms that drive the progression of the disease.  In a previous study, the Sethupathy lab …

Read more

Get In Touch
map marker
20 Horseneck Lane
2nd Floor
Greenwich, CT 06830
phone
(203) 340-7800
mail
info@fibrofoundation.org

facebook twitter instagram youtube
Recent Announcements
  • Rare Disease Day logo
    Rare Disease Day 2023February 26, 2023
  • New FCF research grant issued to University of WashingtonJanuary 31, 2023
  • Pre-clinical grant awarded to Dr. Gordan of UCSFJanuary 20, 2023
About FCF

This site does not provide medical advice, diagnosis, or treatment. FCF is a 501 (c) (3) tax exempt public charity.

Charity Navigator Give With Confidence      

  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
  • Donor Privacy Policy
2023 © Fibrolamellar Cancer Foundation